Drug Concentration Analysis System Market Set To Grow From $2.65 Billion In 2026 To $3.57 Billion By 2030 At A CAGR Of 7.7%
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Drug Concentration Analysis System Market Growth Potential: How Will Market Size Change Through 2030?
The market for drug concentration analysis systems has experienced robust expansion over the past few years. This market is projected to expand from $2.46 billion in 2025 to reach $2.65 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 8.0%. Historically, this expansion has been driven by several factors, including the increasing prevalence of chronic diseases, a rise in healthcare spending, the expansion of pharmaceutical research activities, the growing need for therapeutic drug monitoring, and stricter regulatory quality control demands.
The drug concentration analysis system market is set for substantial expansion over the next few years. This market is expected to reach $3.57 billion by 2030, driven by a compound annual growth rate (CAGR) of 7.7%. The projected growth is attributable to escalating investments in healthcare infrastructure, a rising need for precise drug monitoring, the broadening pharmaceutical and biotechnology sectors, increasing adoption of personalized medicine, and greater spending on pharmaceutical research and development. Key trends anticipated during this period include advancements in analytical instrument technology, the emergence of point-of-care drug concentration systems, the integration of automation and high-throughput testing, the utilization of advanced bioanalytics methods, and an increase in regulatory compliance and quality-assurance testing.
Download A Free Sample Report For Comprehensive Market Insights:
Drug Concentration Analysis System Market Opportunity Drivers: What Is Creating New Revenue Potential?
The increasing need for personalized medicine is anticipated to fuel the expansion of the drug concentration analysis system market in the coming years. This medical strategy customizes treatments for individual patients, considering their unique genetic makeup, environmental influences, and lifestyle choices to enhance results and patient care. Growth in demand for personalized medicine stems from progress in genomic technologies, facilitating the accurate detection of genetic variations and the development of specific treatments for individuals. Drug concentration analysis systems significantly contribute to personalized medicine by precisely quantifying medication levels in patients, thereby allowing for customized dosing and refined treatment plans. These systems boost therapeutic effectiveness by reducing adverse effects and guaranteeing that every patient receives the safest and most potent medication strategy. For example, data from February 2024, provided by the US-based nonprofit Personalized Medicine Coalition (PMC), shows that the U.S. Food and Drug Administration (FDA) sanctioned 26 new personalized medicines in 2023, a notable rise from the 12 approved in 2022. Consequently, the growing requirement for personalized medicine is a key factor propelling the expansion of the drug concentration analysis system market.
Drug Concentration Analysis System Market Segmentation: How Is The Market Structured Across Key Categories?
The drug concentration analysis system market covered in this report is segmented –
1) By Product Type: Liquid Chromatography Systems, Mass Spectrometry Systems, Spectrophotometry Systems, Immunoassays
2) By Sample Type: Blood Or Plasma Or Serum, Urine, Tissue Samples, Saliva, Cell Culture And Bioprocess Samples, Cerebrospinal Fluid (CSF), Other Biological Or Chemical Matrices
3) By Distribution Channel: Online Distribution, Offline Distribution, Direct Sales, Third Party Distributors, Retail Outlets
4) By Application: Therapeutic Drug Monitoring, Pharmaceutical Research And Development, Clinical Trials, Bioavailability Or Bioequivalence
5) By End-User: Hospitals And Clinics, Pharmaceutical Companies, Contract Research Organizations (CROs), Academic And Research Institutions, Homecare Settings
Subsegments:
1) By Liquid Chromatography Systems: High Performance Liquid Chromatography, Ultra High Performance Liquid Chromatography, Fast Protein Liquid Chromatography, Ion Exchange Liquid Chromatography, Size Exclusion Liquid Chromatography
2) By Mass Spectrometry Systems: Quadrupole Mass Spectrometry, Time Of Flight Mass Spectrometry, Ion Trap Mass Spectrometry, Fourier Transform Ion Cyclotron Resonance Mass Spectrometry, Orbitrap Mass Spectrometry
3) By Spectrophotometry Systems: Ultraviolet Visible Spectrophotometry, Infrared Spectrophotometry, Fluorescence Spectrophotometry, Atomic Absorption Spectrophotometry, Raman Spectrophotometry
4) By Immunoassays: Enzyme Linked Immunosorbent Assay, Radioimmunoassay, Chemiluminescent Immunoassay, Fluoroimmunoassay, Lateral Flow Immunoassay
Drug Concentration Analysis System Market Innovation Trends Driving Future Development
Leading companies in the drug concentration analysis system market are dedicating efforts to developing advanced products, notably rapid on-site testing platforms, with the goal of optimizing treatment, improving personalized care, and reducing the time and costs typically associated with traditional laboratory testing. Rapid on-site testing platforms are defined as advanced diagnostic systems designed to provide immediate, quantitative measurements of drug levels within a clinical setting. For example, in October 2023, ProciseDx Inc., a US-based in vitro diagnostics company, obtained de novo FDA clearance for its therapeutic drug monitoring (TDM) tests specifically for adalimumab (found in Humira and biosimilar Amgevita) and infliximab (found in Remicade and biosimilars Inflectra and Renflexis). These assays, known as Procise ADL and Procise IFX, employ time-resolved fluorescence resonance energy transfer immunoassay technology to accurately quantify drug concentrations in serum, producing results in approximately five minutes, which facilitates near-immediate clinical decisions during patient visits. This launch underscores a significant movement toward point-of-care drug concentration analysis systems that combine quantitative precision with operational simplicity, supporting personalized dosing strategies for individuals with conditions like inflammatory bowel disease.
Drug Concentration Analysis System Market Competitive Landscape And Leading Companies
Major companies operating in the drug concentration analysis system market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Siemens Healthineers AG, Danaher Corporation, Agilent Technologies Inc., BioMérieux Inc., Sartorius AG, Shimadzu Corporation, PerkinElmer Inc., Bruker Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Tecan Group Ltd., Randox Laboratories Ltd., Analytik Jena GmbH & Co. KG, KNAUER Wissenschaftliche Geräte GmbH, Chromsystems Instruments & Chemicals GmbH, American Laboratory Products Company Ltd.
Access The Complete Drug Concentration Analysis System Market Report:
Drug Concentration Analysis System Market Regional Outlook: Where Are The Largest Opportunities Located?
North America was the largest region in the drug concentration analysis system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug concentration analysis system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
